DK3873432T3 - Tetracyclinkomplekser med vedvarende aktivitet - Google Patents
Tetracyclinkomplekser med vedvarende aktivitet Download PDFInfo
- Publication number
- DK3873432T3 DK3873432T3 DK19804637.7T DK19804637T DK3873432T3 DK 3873432 T3 DK3873432 T3 DK 3873432T3 DK 19804637 T DK19804637 T DK 19804637T DK 3873432 T3 DK3873432 T3 DK 3873432T3
- Authority
- DK
- Denmark
- Prior art keywords
- sustained activity
- tetracycline
- complexes
- tetracycline complexes
- sustained
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
- C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18203133.6A EP3646852A1 (en) | 2018-10-29 | 2018-10-29 | Tetracycline complexes with sustained activity |
EP19193328 | 2019-08-23 | ||
PCT/EP2019/079566 WO2020089249A1 (en) | 2018-10-29 | 2019-10-29 | Tetracycline complexes with sustained activity |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3873432T3 true DK3873432T3 (da) | 2022-12-19 |
Family
ID=68581748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK19804637.7T DK3873432T3 (da) | 2018-10-29 | 2019-10-29 | Tetracyclinkomplekser med vedvarende aktivitet |
Country Status (13)
Country | Link |
---|---|
US (1) | US20210401996A1 (da) |
EP (1) | EP3873432B1 (da) |
JP (1) | JP7506679B2 (da) |
KR (1) | KR20210086654A (da) |
CN (1) | CN113557008A (da) |
AU (1) | AU2019370918A1 (da) |
BR (1) | BR112021007969A2 (da) |
CA (1) | CA3112910A1 (da) |
DK (1) | DK3873432T3 (da) |
ES (1) | ES2934605T3 (da) |
PH (1) | PH12021550474A1 (da) |
PL (1) | PL3873432T3 (da) |
WO (1) | WO2020089249A1 (da) |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0234325B2 (ja) * | 1985-11-22 | 1990-08-02 | Sansutaa Kk | Shishushitsukanchiryoyososeibutsu |
US4568536A (en) * | 1985-02-08 | 1986-02-04 | Ethicon, Inc. | Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition |
US5981499A (en) * | 1998-02-20 | 1999-11-09 | Atlantic Biomed Corporation | Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
BR0115772A (pt) | 2000-11-29 | 2004-01-13 | Oculex Pharm Inc | Processos para a redução ou para a prevenção da rejeição ao transplante ocular e de implantes intraoculares para uso para o mesmo |
ES2391385T3 (es) | 2003-04-07 | 2012-11-23 | Supernus Pharmaceuticals, Inc. | Formulaciones de doxiciclinas en dosis única diaria |
EP1617785A2 (en) | 2003-04-14 | 2006-01-25 | Shire Laboratories Inc. | Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem |
CN103040773A (zh) * | 2003-07-25 | 2013-04-17 | 沃纳奇尔科特有限责任公司 | 多西环素金属络合物固体剂型 |
ES2588584T3 (es) | 2005-01-21 | 2016-11-03 | Warner Chilcott Company, Llc | Un complejo metálico de tetraciclina en una forma de dosificación sólida |
CN102688492A (zh) | 2007-03-23 | 2012-09-26 | 分子研究中心公司 | 包含四环素类的抗炎组合物及其用途 |
KR101319420B1 (ko) * | 2011-03-18 | 2013-10-17 | 한남대학교 산학협력단 | 서방형 방출이 가능한 수용성 양이온 약물 전달 시스템 |
CN103356910A (zh) | 2013-06-14 | 2013-10-23 | 沈阳创达技术交易市场有限公司 | 一种用于治疗痱子的药物 |
US11103517B2 (en) * | 2015-04-07 | 2021-08-31 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions for minocycline |
CN108324700A (zh) * | 2018-04-07 | 2018-07-27 | 青岛润博特生物科技有限公司 | 一种肠溶缓释土霉素钙预混剂及其制备方法 |
-
2019
- 2019-10-29 JP JP2021547925A patent/JP7506679B2/ja active Active
- 2019-10-29 KR KR1020217015248A patent/KR20210086654A/ko unknown
- 2019-10-29 EP EP19804637.7A patent/EP3873432B1/en active Active
- 2019-10-29 ES ES19804637T patent/ES2934605T3/es active Active
- 2019-10-29 BR BR112021007969-6A patent/BR112021007969A2/pt unknown
- 2019-10-29 CA CA3112910A patent/CA3112910A1/en active Pending
- 2019-10-29 US US17/289,661 patent/US20210401996A1/en active Pending
- 2019-10-29 DK DK19804637.7T patent/DK3873432T3/da active
- 2019-10-29 CN CN201980071554.1A patent/CN113557008A/zh active Pending
- 2019-10-29 WO PCT/EP2019/079566 patent/WO2020089249A1/en unknown
- 2019-10-29 AU AU2019370918A patent/AU2019370918A1/en active Pending
- 2019-10-29 PL PL19804637.7T patent/PL3873432T3/pl unknown
-
2021
- 2021-03-05 PH PH12021550474A patent/PH12021550474A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2022513388A (ja) | 2022-02-07 |
EP3873432B1 (en) | 2022-11-23 |
CN113557008A (zh) | 2021-10-26 |
AU2019370918A1 (en) | 2021-03-18 |
KR20210086654A (ko) | 2021-07-08 |
WO2020089249A1 (en) | 2020-05-07 |
CA3112910A1 (en) | 2020-05-07 |
EP3873432A1 (en) | 2021-09-08 |
ES2934605T3 (es) | 2023-02-23 |
JP7506679B2 (ja) | 2024-06-26 |
US20210401996A1 (en) | 2021-12-30 |
PH12021550474A1 (en) | 2021-11-22 |
BR112021007969A2 (pt) | 2021-07-27 |
PL3873432T3 (pl) | 2023-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3643284T3 (da) | Plejeseng | |
DK3687994T3 (da) | Gadolinium-bærende pcta-baserede kontrastmidler | |
DK3619201T3 (da) | Herbicidvirksomme 4-difluormethylbenzoylamider | |
DK3788912T3 (da) | Stolearrangement | |
UA38958S (uk) | Монітор з базовим блоком | |
DK3778573T3 (da) | Forbindelse med anticanceraktivitet | |
DK3648723T3 (da) | Plejeseng | |
DK3873432T3 (da) | Tetracyclinkomplekser med vedvarende aktivitet | |
ES1221154Y (es) | Equipo salvavidas | |
DK3484852T3 (da) | Benzo-n-hydroxyamidforbindelser med antitumor-aktivitet | |
PT3873432T (pt) | Complexos de tetraciclina com atividade prolongada | |
ES1227004Y (es) | Guarda objetos | |
DE112020003471A5 (de) | Sitzanordnung | |
JP1657235S (ja) | 椅子 | |
TH187286B (th) | เก้าอี้ | |
UA40891S (uk) | Стілець | |
UA40892S (uk) | Стілець | |
UA41072S (uk) | Стілець | |
IT201900003807A1 (it) | Composti ad attività antiparassitaria | |
ES1242094Y (es) | Canape | |
UA41902S (uk) | Шрифт | |
TH191182S (th) | รถแทรกเตอร์ | |
TH191181S (th) | รถแทรกเตอร์ | |
UA38588S (uk) | Фрезер | |
ES1232839Y (es) | Maqueta tiflológica sensor-táctil |